RDHL
Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)
RDHL Filings
Filing Date
Form Description
Form Type
2026-01-05
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-05 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-31
Form F-1 - Registration statement for certain foreign private issuers
2025-12-31 ·
Form F-1 - Registration statement for certain foreign private issuers
2025-12-31
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Financials
2025-12-31 · Financials
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-23
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-23 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-15
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-15 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-26
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-26 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
